Complement kidney disease von zipfel peter (18 Ergebnisse)

Zustand: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.

Zustand: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.

Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

Hardcover. Zustand: New. In shrink wrap. Looks like an interesting title.

Hardcover. Zustand: New. In shrink wrap. Looks like an interesting title.

Zustand: New.

Zustand: Used. pp. 260.

Zustand: New. It is evident that a defective or deregulated complement system results in kidney diseases. An important role of complement effector and regulatory proteins in pathological settings of the kidney has been demonstrated. This book discusses Molecular biology, clinics and therapy. Editor(s): Zipfel, Peter F. Series: Progress in Inflammation Research. Num Pages: 252 pages, biography. BIC Classification: MFG; MJCM; MJR; MMFM; PSF. Category: (P) Professional & Vocational. Dimension: 235 x 155 x 16. Weight in Grams: 603. . 2005. 2006th Edition. hardcover. . . . . …

Zustand: Used. pp. 260 Illus.

Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - It is evident that a defective or deregulated complement system results in kidney diseases. An important role of complement effector and regulatory proteins in pathological settings of the kidney has been demonstrated. A large panel of distinct human kidney diseases is caused by defective complement control. Genetic analyses have identified mutations in complement regulators that are associated with these diseases. Mutations have been identified in the fluid phase alternative pathway regulator Factor H and the membrane regulator Membrane Cofactor Protein MCP (CD46). The functional characterization of the mutant proteins allows to define the pathophysiological events on a molecular level. These new concepts and data on disease mechanisms allowed establishing new diagnostic and promising therapeutic approaches for several human kidney diseases. Molecular biology, clinics and therapy are discussed in this volume.…

Zustand: Used. pp. 260.

Hardcover. Zustand: Brand New. 1st edition. 236 pages. 9.00x6.50x0.75 inches. In Stock.

Zustand: New. It is evident that a defective or deregulated complement system results in kidney diseases. An important role of complement effector and regulatory proteins in pathological settings of the kidney has been demonstrated. This book discusses Molecular biology, clinics and therapy. Editor(s): Zipfel, Peter F. Series: Progress in Inflammation Research. Num Pages: 252 pages, biography. BIC Classification: MFG; MJCM; MJR; MMFM; PSF. Category: (P) Professional & Vocational. Dimension: 235 x 155 x 16. Weight in Grams: 603. . 2005. 2006th Edition. hardcover. . . . . Books ship from the US and Ireland. …

Hardcover. Zustand: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

Zustand: As New. Unread book in perfect condition.

Buch. Zustand: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -It is evident that a defective or deregulated complement system results in kidney diseases. An important role of complement effector and regulatory proteins in pathological settings of the kidney has been demonstrated. A large panel of distinct human kidney diseases is caused by defective complement control. Genetic analyses have identified mutations in complement regulators that are associated with these diseases. Mutations have been identified in the fluid phase alternative pathway regulator Factor H and the membrane regulator Membrane Cofactor Protein MCP (CD46). The functional characterization of the mutant proteins allows to define the pathophysiological events on a molecular level. These new concepts and data on disease mechanisms allowed establishing new diagnostic and promising therapeutic approaches for several human kidney diseases. Molecular biology, clinics and therapy are discussed in this volume. 236 pp. Englisch.…

Gebunden. Zustand: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Role of genetic mutations in regulator proteinsNew therapies in human kidney diseasesProf. Zipfel is a well renowned scientist in this area of researchThe understanding how complement relates to glomerular diseaseshas evolved con.…

Buch. Zustand: Neu. This item is printed on demand - Print on Demand Titel. Neuware -It is evident that a defective or deregulated complement system results in kidney diseases. An important role of complement effector and regulatory proteins in pathological settings of the kidney has been demonstrated. A large panel of distinct human kidney diseases is caused by defective complement control. Genetic analyses have identified mutations in complement regulators that are associated with these diseases. Mutations have been identified in the fluid phase alternative pathway regulator Factor H and the membrane regulator Membrane Cofactor Protein MCP (CD46). The functional characterization of the mutant proteins allows to define the pathophysiological events on a molecular level. These new concepts and data on disease mechanisms allowed establishing new diagnostic and promising therapeutic approaches for several human kidney diseases. Molecular biology, clinics and therapy are discussed in this volume.Springer Nature c/o IBS, Benzstrasse 21, 48619 Heek 260 pp. Englisch.…